<p><i>Note</i>. HOME-IR = Homeostasis Model Assessment Insulin Resistance. HDL = high-density lipoprotein.</p><p>Prevalence of individual components of the metabolic syndrome in participants with and without chronic kidney disease.</p
OBJECTIVES: The effects of ethnicity and gender can produce varying results when evaluating risk of ...
The prevalence of metabolic syndrome (MetS) is increasing worldwide in both developing and developed...
Introduction: Approximately 26.3 million people in the United States have chronic kidney disease and...
<p><i>Note</i>. Demographics = age, gender, race, education, smoking and alcohol intake. hsCRP = hig...
<p>OR, odds ratio; CI, confidence interval; HDL, high density lipoprotein.</p>a<p>Adjusted for age, ...
<p><i>Note</i>. Demographics = age, gender, race, education, smoking and alcohol intake. hsCRP = hig...
Aims: we investigate whether insulin resistance is associated with an increased prevalence for chron...
<p>Prevalence of metabolic syndrome<sup>*</sup> and its components in individuals with or without IF...
<p>GFR, glomerular filtration rate; CI, confidence interval; OR, odds ratio; HDL, high-density lipop...
Objective The global prevalence of metabolic syndrome (MetS) appears to be increasing and the impact...
Approximately 26.3 million people in the United States have chronic kidney disease and many more are...
<p>Prevalence of the individual components of metabolic syndrome in the study and control groups.</p
<p><i>Note</i>. Demographics = age, gender, race, education, smoking and alcohol intake. hsCRP = hig...
Background: Insulin resistance has been noted in patients with chronic kidney disease (CKD). The det...
Background: There is dyslipidaemia in metabolic syndrome (MetS). Lipid profiles in MetS associated w...
OBJECTIVES: The effects of ethnicity and gender can produce varying results when evaluating risk of ...
The prevalence of metabolic syndrome (MetS) is increasing worldwide in both developing and developed...
Introduction: Approximately 26.3 million people in the United States have chronic kidney disease and...
<p><i>Note</i>. Demographics = age, gender, race, education, smoking and alcohol intake. hsCRP = hig...
<p>OR, odds ratio; CI, confidence interval; HDL, high density lipoprotein.</p>a<p>Adjusted for age, ...
<p><i>Note</i>. Demographics = age, gender, race, education, smoking and alcohol intake. hsCRP = hig...
Aims: we investigate whether insulin resistance is associated with an increased prevalence for chron...
<p>Prevalence of metabolic syndrome<sup>*</sup> and its components in individuals with or without IF...
<p>GFR, glomerular filtration rate; CI, confidence interval; OR, odds ratio; HDL, high-density lipop...
Objective The global prevalence of metabolic syndrome (MetS) appears to be increasing and the impact...
Approximately 26.3 million people in the United States have chronic kidney disease and many more are...
<p>Prevalence of the individual components of metabolic syndrome in the study and control groups.</p
<p><i>Note</i>. Demographics = age, gender, race, education, smoking and alcohol intake. hsCRP = hig...
Background: Insulin resistance has been noted in patients with chronic kidney disease (CKD). The det...
Background: There is dyslipidaemia in metabolic syndrome (MetS). Lipid profiles in MetS associated w...
OBJECTIVES: The effects of ethnicity and gender can produce varying results when evaluating risk of ...
The prevalence of metabolic syndrome (MetS) is increasing worldwide in both developing and developed...
Introduction: Approximately 26.3 million people in the United States have chronic kidney disease and...